Key result
Limited annual hypertension screening improves specificity by ~12% vs routine screening without compromising sensitivity.
Why the study?
Does a limited annual blood pressure screening strategy improve specificity without sacrificing sensitivity compared to routine screening at every visit in previously normotensive adults?
Case-Control (n=440)
No
Does a limited annual blood pressure screening strategy improve specificity without sacrificing sensitivity compared to routine screening at every visit in previously normotensive adults?
Absolute Event Rate: 82% vs 70.4%
An annual blood pressure screening strategy in low-risk adults improves diagnostic specificity and reduces false positives compared to screening at every visit, without significantly compromising sensitivity.
No takes yet. Share an insight, caveat, or question.
Annual screening may raise specificity without sensitivity loss in normotensive adults; leaves open whether it should replace per-visit measurement.
Garrison et al. (2013) conducted a case-control in Hypertension screening (n=440). Annual blood pressure screening vs. Routine blood pressure screening at every visit was evaluated on Specificity of screening for hypertension. A limited annual screening strategy for hypertension improved specificity to 82.0% compared to 70.4% with routine screening at every visit, without a statistically significant difference in sensitivity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: